{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:18:17Z","timestamp":1788380297049,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T00:00:00Z","timestamp":1429056000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["In Vitro Cell.Dev.Biol.-Animal"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11626-015-9885-z","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T18:32:18Z","timestamp":1429036338000},"page":"714-721","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line"],"prefix":"10.1007","volume":"51","author":[{"given":"Walter","family":"Blum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e1szl\u00f3","family":"Pecze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Felley-Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine","family":"Worthm\u00fcller-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Vrugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"de Perrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Schwaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,15]]},"reference":[{"key":"9885_CR1","doi-asserted-by":"crossref","first-page":"8090","DOI":"10.1158\/0008-5472.CAN-05-2312","volume":"65","author":"DA Altomare","year":"2005","unstructured":"Altomare DA (2005) A mouse model recapitulating molecular features of human mesothelioma. Cancer Res 65:8090\u20138095. doi: 10.1158\/0008-5472.CAN-05-2312","journal-title":"Cancer Res"},{"key":"9885_CR2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1146\/annurev-micro-092611-150154","volume":"66","author":"P An","year":"2012","unstructured":"An P, S\u00e1enz Robles MT, Pipas JM (2012) Large T antigens of polyomaviruses: amazing molecular machines. Annu Rev Microbiol 66:213\u2013236. doi: 10.1146\/annurev-micro-092611-150154","journal-title":"Annu Rev Microbiol"},{"key":"9885_CR3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0092-8674(02)00622-0","volume":"108","author":"A Balmain","year":"2002","unstructured":"Balmain A (2002) Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models. Cell 108:145\u2013152. doi: 10.1016\/S0092-8674(02)00622-0","journal-title":"Cell"},{"key":"9885_CR4","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1073\/pnas.92.24.10854","volume":"92","author":"AB Bianchi","year":"1995","unstructured":"Bianchi AB, Mitsunaga SI, Cheng JQ et al (1995) High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas. Proc Natl Acad Sci U S A 92:10854\u201310858","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9885_CR5","first-page":"162","volume":"6","author":"C Bianchi","year":"1997","unstructured":"Bianchi C, Giarelli L, Grandi G et al (1997) Latency periods in asbestos-related mesothelioma of the pleura. Eur J Cancer Prev 6:162\u2013166","journal-title":"Eur J Cancer Prev"},{"key":"9885_CR6","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1002\/ijc.28218","volume":"133","author":"W Blum","year":"2013","unstructured":"Blum W, Schwaller B (2013) Calretinin is essential for mesothelioma cell growth\/survival in vitro: a potential new target for malignant mesothelioma therapy? Int J Cancer 133:2077\u20132088. doi: 10.1002\/ijc.28218","journal-title":"Int J Cancer"},{"key":"9885_CR7","doi-asserted-by":"crossref","first-page":"10214","DOI":"10.1073\/pnas.170207097","volume":"97","author":"M Bocchetta","year":"2000","unstructured":"Bocchetta M, Di Resta I, Powers A et al (2000) Human mesothelial cells are unusually susceptible to simian virus 40-mediated transformation and asbestos cocarcinogenicity. Proc Natl Acad Sci U S A 97:10214\u201310219","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9885_CR8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1078\/0344-0338-00427","volume":"199","author":"J Bot","year":"2003","unstructured":"Bot J, Whitaker D, Vivian J et al (2003) Culturing mouse peritoneal mesothelial cells. Pathol Res Pract 199:341\u2013344. doi: 10.1078\/0344-0338-00427","journal-title":"Pathol Res Pract"},{"key":"9885_CR9","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1038\/sj.onc.1206552","volume":"22","author":"M Carbone","year":"2003","unstructured":"Carbone M, Pass HI, Miele L, Bocchetta M (2003) New developments about the association of SV40 with human mesothelioma. Oncogene 22:5173\u20135180. doi: 10.1038\/sj.onc.1206552","journal-title":"Oncogene"},{"key":"9885_CR10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","volume":"227","author":"M Carbone","year":"2011","unstructured":"Carbone M, Ly BH, Dodson RF et al (2011) Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol 227:44\u201358. doi: 10.1002\/jcp.22724","journal-title":"J Cell Physiol"},{"key":"9885_CR11","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1200\/JCO.2013.49.9616","volume":"31","author":"LR Chirieac","year":"2013","unstructured":"Chirieac LR, Barletta JA, Yeap BY et al (2013) Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma. J Clin Oncol 31:4544\u20134549. doi: 10.1200\/JCO.2013.49.9616","journal-title":"J Clin Oncol"},{"key":"9885_CR12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/carcin\/bgt322","volume":"35","author":"AL Cleaver","year":"2014","unstructured":"Cleaver AL, Bhamidipaty K, Wylie B et al (2014) Long-term exposure of mesothelial cells to SV40 and asbestos leads to malignant transformation and chemotherapy resistance. Carcinogenesis 35:407\u2013414. doi: 10.1093\/carcin\/bgt322","journal-title":"Carcinogenesis"},{"key":"9885_CR13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0092-8674(83)90155-1","volume":"34","author":"ND Connell","year":"1983","unstructured":"Connell ND, Rheinwald JG (1983) Regulation of the cytoskeleton in mesothelial cells: reversible loss of keratin and increase in vimentin during rapid growth in culture. Cell 34:245\u2013253","journal-title":"Cell"},{"key":"9885_CR14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/sj.cgt.7700594","volume":"10","author":"L Cordier Kellerman","year":"2003","unstructured":"Cordier Kellerman L, Valeyrie L, Fernandez N et al (2003) Regression of AK7 malignant mesothelioma established in immunocompetent mice following intratumoral gene transfer of interferon gamma. Cancer Gene Ther 10:481\u2013490. doi: 10.1038\/sj.cgt.7700594","journal-title":"Cancer Gene Ther"},{"key":"9885_CR15","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/ijc.2910520609","volume":"52","author":"JM Davis","year":"1992","unstructured":"Davis JM, Manning LS, Whitaker D et al (1992) Establishment of a murine model of malignant mesothelioma. Int J Cancer 52:881\u2013886. doi: 10.1002\/ijc.2910520609","journal-title":"Int J Cancer"},{"key":"9885_CR16","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<554::AID-IJC14>3.0.CO;2-6","volume":"77","author":"BB Deguen","year":"1998","unstructured":"Deguen BB, Goutebroze LL, Giovannini MM et al (1998) Heterogeneity of mesothelioma cell lines as defined by altered genomic structure and expression of the NF2 gene. Int J Cancer 77:554\u2013560. doi: 10.1002\/(SICI)1097-0215(19980812)77:4<554::AID-IJC14>3.0.CO;2-6","journal-title":"Int J Cancer"},{"key":"9885_CR17","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1093\/carcin\/bgr127","volume":"32","author":"C Frei","year":"2011","unstructured":"Frei C, Opitz I, Soltermann A et al (2011) Pleural mesothelioma side populations have a precursor phenotype. Carcinogenesis 32:1324\u20131332. doi: 10.1093\/carcin\/bgr127","journal-title":"Carcinogenesis"},{"key":"9885_CR18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ccr.2008.01.030","volume":"13","author":"J Jongsma","year":"2008","unstructured":"Jongsma J, van Montfort E, Vooijs M et al (2008) A conditional mouse model for malignant mesothelioma. Cancer Cell 13:261\u2013271. doi: 10.1016\/j.ccr.2008.01.030","journal-title":"Cancer Cell"},{"key":"9885_CR19","first-page":"979","volume":"134","author":"YY Ke","year":"1989","unstructured":"Ke YY, Reddel RRR, Gerwin BIB et al (1989) Establishment of a human in vitro mesothelial cell model system for investigating mechanisms of asbestos-induced mesothelioma. Am J Pathol 134:979\u2013991","journal-title":"Am J Pathol"},{"key":"9885_CR20","doi-asserted-by":"crossref","first-page":"14128","DOI":"10.1073\/pnas.0604544103","volume":"103","author":"B Kroczynska","year":"2006","unstructured":"Kroczynska B, Cutrone R, Bocchetta M et al (2006) Crocidolite asbestos and SV40 are cocarcinogens in human mesothelial cells and in causing mesothelioma in hamsters. Proc Natl Acad Sci U S A 103:14128\u201314133. doi: 10.1073\/pnas.0604544103","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9885_CR21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02620917","volume":"21","author":"PJ Rocca La","year":"1985","unstructured":"La Rocca PJ, Rheinwald JG (1985) Anchorage-independent growth of normal human mesothelial cells: a sensitive bioassay for EGF which discloses the absence of this factor in fetal calf serum. In Vitro Cell Dev Biol 21:67\u201372","journal-title":"In Vitro Cell Dev Biol"},{"key":"9885_CR22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/mutage\/15.3.239","volume":"15","author":"V Levresse","year":"2000","unstructured":"Levresse V, Renier A, Levy F et al (2000) DNA breakage in asbestos-treated normal and transformed (TSV40) rat pleural mesothelial cells. Mutagenesis 15:239\u2013244","journal-title":"Mutagenesis"},{"key":"9885_CR23","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1158\/0008-5472.CAN-05-3727","volume":"67","author":"JR Pietruska","year":"2007","unstructured":"Pietruska JR, Kane AB (2007) SV40 oncoproteins enhance asbestos-induced DNA double-strand breaks and abrogate senescence in murine mesothelial cells. Cancer Res 67:3637\u20133645. doi: 10.1158\/0008-5472.CAN-05-3727","journal-title":"Cancer Res"},{"key":"9885_CR24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s13402-011-0068-y","volume":"35","author":"JJ Provost","year":"2012","unstructured":"Provost JJ, Rastedt D, Canine J et al (2012) Urokinase plasminogen activator receptor induced non-small cell lung cancer invasion and metastasis requires NHE1 transporter expression and transport activity. Cell Oncol 35:95\u2013110","journal-title":"Cell Oncol"},{"key":"9885_CR25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0092-8674(78)90101-0","volume":"15","author":"WC Raschke","year":"1978","unstructured":"Raschke WC, Baird S, Ralph P, Nakoinz I (1978) Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15:261\u2013267","journal-title":"Cell"},{"key":"9885_CR26","doi-asserted-by":"crossref","first-page":"e12","DOI":"10.1017\/erm.2012.6","volume":"14","author":"PA Rascoe","year":"2012","unstructured":"Rascoe PA, Jupiter D, Cao X et al (2012) Molecular pathogenesis of malignant mesothelioma. Expert Rev Mol Med 14:e12. doi: 10.1017\/erm.2012.6","journal-title":"Expert Rev Mol Med"},{"key":"9885_CR27","doi-asserted-by":"crossref","first-page":"10786","DOI":"10.1158\/0008-5472.CAN-05-4668","volume":"66","author":"C Robinson","year":"2006","unstructured":"Robinson C, van Bruggen I, Segal A et al (2006) A novel SV40 TAg transgenic model of asbestos-induced mesothelioma: malignant transformation is dose dependent. Cancer Res 66:10786\u201310794. doi: 10.1158\/0008-5472.CAN-05-4668","journal-title":"Cancer Res"},{"key":"9885_CR28","first-page":"1227","volume":"55","author":"YY Sekido","year":"1995","unstructured":"Sekido YY, Pass HIH, Bader SS et al (1995) Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 55:1227\u20131231","journal-title":"Cancer Res"},{"key":"9885_CR29","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1365-2184.2008.00560.x","volume":"41","author":"AL Sherwood","year":"2008","unstructured":"Sherwood AL, Mutsaers SE, Peeva VK et al (2008) Spontaneously immortalized mouse mesothelial cells display characteristics of malignant transformation. Cell Prolif 41:894\u2013908. doi: 10.1111\/j.1365-2184.2008.00560.x","journal-title":"Cell Prolif"},{"key":"9885_CR30","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1290\/0604027.1","volume":"42","author":"KSMK Smalley","year":"2006","unstructured":"Smalley KSMK, Lioni MM, Herlyn MM (2006) Life isn\u2019t flat: taking cancer biology to the next dimension. In Vitro Cell Dev Biol Anim 42:242\u2013247. doi: 10.1290\/0604027.1","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"9885_CR31","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ctrv.2011.01.001","volume":"37","author":"PA Zucali","year":"2011","unstructured":"Zucali PA, Ceresoli GL, De Vincenzo F et al (2011) Advances in the biology of malignant pleural mesothelioma. Cancer Treat Rev 37:543\u2013558. doi: 10.1016\/j.ctrv.2011.01.001","journal-title":"Cancer Treat Rev"},{"key":"9885_CR32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11248-010-9403-8","volume":"20","author":"E Zurita","year":"2011","unstructured":"Zurita E, Chagoyen M, Cantero M et al (2011) Genetic polymorphisms among C57BL\/6 mouse inbred strains. Transgenic Res 20:481\u2013489. doi: 10.1007\/s11248-010-9403-8","journal-title":"Transgenic Res"}],"updated-by":[{"DOI":"10.1007\/s11626-017-0194-6","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T00:00:00Z","timestamp":1503532800000}}],"container-title":["In Vitro Cellular &amp; Developmental Biology - Animal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-015-9885-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11626-015-9885-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11626-015-9885-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T23:15:40Z","timestamp":1553642140000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11626-015-9885-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,15]]},"references-count":32,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["9885"],"URL":"https:\/\/doi.org\/10.1007\/s11626-015-9885-z","relation":{"erratum":[{"id-type":"doi","id":"10.1007\/s11626-017-0194-6","asserted-by":"object"}]},"ISSN":["1071-2690","1543-706X"],"issn-type":[{"value":"1071-2690","type":"print"},{"value":"1543-706X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,15]]}}}